Newcastle Disease Virus (NDV) Marker Vaccine: an Immunodominant Epitope on the Nucleoprotein Gene of NDV Can Be Deleted or Replaced by a Foreign Epitope
Open Access
- 15 October 2002
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 76 (20), 10138-10146
- https://doi.org/10.1128/jvi.76.20.10138-10146.2002
Abstract
The nucleoprotein (NP) of Newcastle disease virus (NDV) functions primarily to encapsidate the virus genome for the purpose of RNA transcription, replication, and packaging. This conserved multifunctional protein is also efficient in inducing NDV-specific antibody in chickens. Here, we localized a conserved B-cell immunodominant epitope (IDE) spanning residues 447 to 455 and successfully generated a recombinant NDV lacking the IDE by reverse genetics. Despite deletion of NP residues 443 to 460 encompassing the NP-IDE, the mutant NDV propagated in embryonated specific-pathogen-free chicken eggs to a level comparable to that of the parent virus. In addition, a B-cell epitope of the S2 glycoprotein of murine hepatitis virus (MHV) was inserted in-frame to replace the NP-IDE. Recombinant viruses properly expressing the introduced MHV epitope were successfully generated, demonstrating that the NP-IDE not only is dispensable for virus replication but also can be replaced by foreign sequences. Chickens immunized with the hybrid recombinants produced specific antibodies against the S2 glycoprotein of MHV and completely lacked antibodies directed against the NP-IDE. These marked-NDV recombinants, in conjunction with a diagnostic test, enable serological differentiation of vaccinated animals from infected animals and may be useful tools in ND eradication programs. The identification of a mutation-permissive region on the NP gene allows a rational approach to the insertion of protective epitopes and may be relevant for the design of NDV-based cross-protective marker vaccines.Keywords
This publication has 29 references indexed in Scilit:
- Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of Erns or E2 of CSFVVaccine, 2002
- A Recombinant Newcastle Disease Virus with Low-Level V Protein Expression Is Immunogenic and Lacks Pathogenicity for Chicken EmbryosJournal of Virology, 2001
- A New Quantitative Method for Rabies Virus by Detection of Nucleoprotein in Virion Using ELISA.The Journal of Veterinary Medical Science, 1999
- NONSEGMENTED NEGATIVE-STRAND RNA VIRUSES: Genetics and Manipulation of Viral GenomesAnnual Review of Genetics, 1998
- Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. Presentation of foreign epitopesJournal of Biotechnology, 1996
- A diagnostic immunoassay for Newcastle disease virus based on the nucleocapsid protein expressed by a recombinant baculovirusJournal of Virological Methods, 1995
- Production of measles nucleoprotein in different expression systems and its use as a diagnostic reagentJournal of Virological Methods, 1994
- Potential Use of Poliovirus as a VectorBiologicals, 1993
- Avian herpesvirus as a live viral vector for the expression of heterologous antigensVaccine, 1993
- Protection of Chickens from Newcastle and Marek's Diseases with a Recombinant Herpesvirus of Turkeys Vaccine Expressing the Newcastle Disease Virus Fusion ProteinAvian Diseases, 1992